http://www.animalci.com Animal Clinical Investigation: Novel Treatment Options Provide Hope for Pets Tue, 20 Jul 2010 15:22:44 +0000 http://backend.userland.com/rss092 en Trial Summary This clinical trial will evaluate a novel anti-cancer agent in a limited number of dogs with hemangiosarcoma. All dogs will receive study drug; there is no placebo. Dogs will receive the study drug as daily, oral treatment with evaluations performed once weekly for the first 28 days, then once monthly. ... http://www.animalci.com/trials/funded-clinical-trial-for-dogs-with-hemangiosarcoma Status: Closed Trial Summary Pet dogs that are enrolled in the study will receive a single dose of a novel, oral anti-cancer agent. Serial blood samples and lymph node aspirates will then be collected over a 24-hour period.  Patients will return for evaluation 7 days after the single dose of therapy is ... http://www.animalci.com/trials/closed-trials/clinical-trial-for-canine-lymphoma-now-available Trial Summary A clinical trial to evaluate a novel anti-cancer therapy is now available. The study is designed into two phases. The initial phase will evaluate the safety of this drug in dogs with any measurable cancer (excluding hemangiosarcoma). The 2nd phase will evaluate the safety of this drug in dogs ... http://www.animalci.com/trials/funded-clinical-trial-for-dogs-with-malignant-tumors